Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 1.86
-2.62 %
$ 717 M
Market Cap
13.29
P/E
1. INTRINSIC VALUE
Balance Sheet
Cronos Group Inc.
| Current Assets | 936 M |
| Cash & Short-Term Investments | 859 M |
| Receivables | 29.8 M |
| Other Current Assets | 47.6 M |
| Non-Current Assets | 230 M |
| Long-Term Investments | 2.81 M |
| PP&E | 135 M |
| Other Non-Current Assets | 92.8 M |
| Current Liabilities | 49.7 M |
| Accounts Payable | 17 M |
| Short-Term Debt | 1.02 M |
| Other Current Liabilities | 31.7 M |
| Non-Current Liabilities | 5.63 M |
| Long-Term Debt | 993 K |
| Other Non-Current Liabilities | 4.64 M |
EFFICIENCY
Earnings Waterfall
Cronos Group Inc.
| Revenue | 118 M |
| Cost Of Revenue | 92.4 M |
| Gross Profit | 25.2 M |
| Operating Expenses | 102 M |
| Operating Income | -76.5 M |
| Other Expenses | -117 M |
| Net Income | 40 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Cronos Group Inc.
| Net Income | 40 M |
| Depreciation & Amortization | 9.34 M |
| Capital Expenditures | -13.2 M |
| Stock-Based Compensation | 8.7 M |
| Change in Working Capital | -311 K |
| Others | -36.1 M |
| Free Cash Flow | 6.43 M |
Wall Street Analysts Price Targets
Cronos Group Inc.
Wall Street analysts predict an average 1-year price target for CRON of $3.15 , with forecasts ranging from
a
low of
$2.3 to a high of $4.5 .
CRON Lowest Price Target
Wall Street Target
2.3 USD
23.66%
CRON Average Price Target
Wall Street Target
3.15 USD
69.35%
CRON Highest Price Target
Wall Street Target
4.5 USD
141.94%
4. DIVIDEND
ANALYSIS
CRON does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Cronos Group Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
3 Recession-Resistant Dividend Kings With High Yields
Key Points Dividend Kings are some of the most stable stocks in the market. Their dividends have been hiked through recessions, and the trend is likely to continue. These three pay high yields and are also resistant to recessions. Are you ahead, or behind on retirement? SmartAsset’s free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don’t waste another minute; get started by clicking here.(Sponsor) Dividend Kings are some of the most solid stocks to own in the market. The title means that the company has raised its dividends for the past 50 years straight. This is not a title that any company wants to forgo, so the dividends that Dividend Kings pay are the most stable in the market. Moreover, getting that title in the first place means that these companies would have to have very stable businesses. And they do. Dividend Kings are usually consumer staples, utilities, or are in sectors that are very defensive in nature. This also helps them weather recessions well.Here are three to look into that come with high yields. These yields may not look as high due to Treasury yields, but they’re among the best you’ll get when it comes to Dividend Kings. And the underlying stock also appreciates, unlike Treasuries. Altria Group (MO) Altria Group (NYSE:MO) is a tobacco company. And as you’d expect, this company has very sticky cash flows regardless of the economic environment. Even a recession is not going to change people’s smoking habits overnight. If anything, it’ll cause an increase in smoking rates. One of the biggest arguments for not investing in MO stock is that smoking rates are seeing a gradual decline, especially among the youth. But the notion that young people do not smoke is wrong. It is true they don’t do traditional cigarettes as much, but electronic cigarettes (or vapes) and other alternative products are still popular. Altria is far from dying. It is now betting on e-vapor and nicotine pouches. Regardless, the main business is still on a gradual slope downwards, as even vapes are becoming less popular. People are still buying MO stock as it has an 8% stake in Anheuser-Busch InBev (NYSE:BUD) for global beer exposure, and a 41% stake in Cronos Group (NASDAQ:CRON) for cannabis exposure. On top of that, Altria is considered a premium brand company, and its portfolio is almost exclusively made up of Marlboro. People are willing to pay more for it, and Altria has been using that pricing power to keep its cash flow (and dividends) steady. It’ll take multiple decades for the cash flow to fall markedly. In the meantime, I’d sit on this recession-resistant dividend stock with solid yields. MO stock comes with a dividend yield of 6.88% and 56 years of consecutive dividend hikes. PepsiCo (PEP) PepsiCo (NASDAQ:PEP) is one of the safest stocks in the market right now. The company’s products have solid demand as it dominates snack shelves. Moreover, the valuation is much better now. It trades at just 19 times earnings after a 26.4% decline from its peak, though PEP stock has traded sideways through May. The recent decline is worse than 2008 or 2020 in terms of value and is quite comparable to the pandemic crash in percentage terms. Even if a recession were to hit, I see little downside risk from here, but plenty of long-term upside. This is a well-established company that should recover from the selloff just fine and deliver solid returns in the coming years. In the meantime, you could sit on its 4.31% dividend yield with 54 years of consecutive dividend increases. Historically, Wall Street has paid over 26 times earnings for PEP stock, and even though the growth outlook going forward is not as good as its growth from 2019 to 2023, you should keep in mind that PepsiCo had declining revenue for a good stretch of the early 2010s and still kept an upward trajectory due to the bottom line being resilient. Once interest rate cuts start, that should be the catalyst that finally nudges PepsiCo higher toward its historical trajectory. It posted a net interest loss of $264 million, and if it can receive some relief on that front, along with organic revenue growth turning a corner, Wall Street would have no option but to turn bullish. Northwest Natural Holding (NWN) Northwest Natural Holdings (NYSE:NWN) is a natural gas utility company. Utility stocks are one of the safest names you can invest in due to tariffs making the broader industry more volatile. Utility companies do their business almost entirely domestically, and they don’t have much exposure to trade policy. These companies are also detached from natural gas prices, since their main business is natural gas distribution through pipelines. Northwest Natural also does wastewater management and energy storage. NWN stock is now down over 48% from its highs in 2019. The stock mainly declined due to inflation and rate hikes increasing debt servicing costs. However, most of the bearishness was priced in by late 2023, and the stock has been on an uptrend since. The economic cycle is turning with more rate cuts on the horizon, so more upside is likely in the coming years. In the meantime, you can sit on its 4.93% dividend yield, which has been raised for 70 consecutive years. The dividend payout ratio of 65% is quite good for a utility business.The post 3 Recession-Resistant Dividend Kings With High Yields appeared first on 24/7 Wall St..
https://247wallst.com
- 3 weeks ago
Marijuana Stocks To Watch With Strong Market Potential
At one time the hype on various cannabis stocks was enough to send the market into an upward frenzy. Now not so much however the perspective on the cannabis sector has changed. A once short-term way to make gains is now looking like a promising long-term investment. There is still a large amount of uncertainty and even more with Donald Trump in office. It has been the success of the legal market that has kept people looking for marijuana stocks to buy.
marijuanastocks.com
- 3 weeks ago
Cronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Consumer Conference
TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the TD Cowen 9th Annual Future of the Consumer Conference on Wednesday, June 4, 2025, at 3:30 p.m. EST.
globenewswire.com
- 1 month ago
Cronos Group: Industry Fortress Balance Sheet And FCF Create A Solid Upside Potential
Cronos Group boasts a strong net cash position nearly equal to its market cap, offering downside protection and operational flexibility. Leading brands like Spinach and Lord Jones have secured top market shares in key cannabis segments, driving consistent revenue growth. The company has achieved free cash flow positivity, signaling the end of its capital-intensive phase and disciplined capital allocation.
seekingalpha.com
- 1 month ago
Top Marijuana Stocks In A Volatile Market
Right now, cannabis companies are still reporting Q1 2025 earnings, and for most things, are looking good. It is undeniable how well the cannabis industry is doing, even as the road ahead is still a tough one. Profits are being made and growth is occurring throughout the sector.
marijuanastocks.com
- 1 month ago
Cronos Reports Improved Financials For Q1-2025 As Demand Outpaces Supply
Cronos recently reported improved financial performance for Q1-2025. International sales have increased and domestic sales are outpacing supply. The company has a new risk with tariffs in the Israeli medical market.
seekingalpha.com
- 1 month ago
Top 3 Marijuana Stocks For Better Investing 2025
The current state of marijuana stocks could keep some people discouraged. With no federal reform or bills to ease tax burdens and improve banking access, this has led to a downtrend. A volatile wave of downward trading has plagued the sector for some time. People see that money is being made for legal operators, but still, no one feels as safe and protected as they should be.
marijuanastocks.com
- 1 month ago
Cronos Group Inc. (CRON) Q1 2025 Earnings Call Transcript
Cronos Group Inc. (NASDAQ:CRON ) Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ET Company Participants Terry Doucet - General Counsel & Corporate Secretary Mike Gorenstein - Chairman, President & Chief Executive Officer Anna Shlimak - Chief Financial Officer Conference Call Participants Bill Kirk - ROTH Capital Partners Operator Good morning. My name is Jacinda [ph] and I will be your conference operator today.
seekingalpha.com
- 1 month ago
Cronos Group Reports 2025 First Quarter Results
Net revenue in Q1 2025 increased by 28% year-over-year, 33% year-over-year net revenue growth on a constant currency basis
globenewswire.com
- 1 month ago
3 Marijuana Stocks For The Long Term Investing
Marijuana stocks hold lots of potential for home-run investments in the future. In 2018, most pot stocks saw their first wave of the green rush. Yet over the last several years, this has not been the case and things have changed drastically. Still, the way companies are keeping up with. Market demand profits and revenue are steadily rising. However, this success has played very little in how most marijuana stocks trade.
marijuanastocks.com
- 2 months ago
Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 Annual Meeting of Shareholders on Friday, June 20, 2025, at 11:00 a.m. ET.
globenewswire.com
- 2 months ago
3 Canadian Marijuana Stocks That Could See Big Future Gains
When it comes to finding marijuana stocks to buy a happy medium or silver lining at this time is tough to do. Not becuase the low share prices from some of the top-performing companies dont look appetizing. It is more due to the consistent falls in the sector no real upward push. Even as the cannabis industry as a whole is thriving and showing great long-term success.
marijuanastocks.com
- 2 months ago
8. Profile
Summary
Cronos Group Inc. CRON
COUNTRY
CA
INDUSTRY
Drug Manufacturers - Specialty & Generic
MARKET CAP
$ 717 M
Dividend Yield
0.00%
Description
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Contact
111 Peter Street, Stayner, ON, M5V 2H1
https://www.thecronosgroup.com
IPO
Date
Feb. 27, 2018
Employees
459
Officers
Mr. Adam Wagner
Senior Vice President & Head of Cronos Israel
Mr. James Holm
Executive Officer
Mr. James Andrew McGinness III
Vice President, Controller & Principal Accounting Officer
Mr. Michael Ryan Gorenstein J.D.
President, Chief Executive Officer & Chairman
Ms. Anna Shlimak
Chief Financial Officer
Mr. Arye Weigensberg
Senior Vice President and Head of Research & Development
Mr. Jeffrey David Jacobson
Chief Growth Officer
Mr. Terry Gregory-Joseph Doucet
General Counsel & Corporate Secretary
Ms. Shannon Buggy
Senior Vice President & Global Head of People